Blueprint Capital
Research, Innovation, Transformative and Leading-edge Capital
- San Francisco
- New York
- Hong Kong
- Shanghai
About
Billions of US dollars in assets under stewardship worldwide
- Structure
- Privately held investment consortium
- Sectors
- Finance, real estate, manufacturing, artificial intelligence, biotechnology, research, hospitality, and food & beverage
- Offices
- San Francisco, New York, Hong Kong, and Shanghai
Blueprint Capital is a privately held investment consortium. Our portfolio is deliberately diversified across finance, real estate, manufacturing, artificial intelligence, biotechnology, research, hospitality, and food and beverage, among other sectors.
With stewardship over billions of US dollars in assets worldwide, we invest across the full breadth of asset classes, from listed and private equities, bonds, commodities, and derivatives to real estate, digital assets, and collectibles. This breadth allows us to allocate capital to wherever the most compelling opportunities arise.
Our philosophy is to pursue capital appreciation within a framework of rigorous risk management. Through a carefully balanced approach, we seek to capture near-term opportunities without compromising long-term growth, across every asset class and market in which we invest.
Asset classes
- EquitiesListed and unlisted, domestic and international
- BondsGovernment and corporate
- CommoditiesPrecious and industrial metals, agricultural products, and energy
- DerivativesSwaps, options, and futures
- Real EstateResidential and commercial properties
- Digital AssetsCryptocurrencies and other blockchain-based assets
- CollectiblesFine art, rare coins, vintage wine, and stamps
Our focus
-
Multi-Asset
One platform investing across asset classes, geographies, and market cycles.
-
Advanced AI and High-tech
Capital for the artificial intelligence and advanced-technology ventures defining the next decade.
-
Research
Independent research underpins every decision we make and is how we build a deep understanding of each sector we enter.
-
Next-Generation Biotechnology
Substantial, long-term commitments to the development of next-generation biologics.
“Patience to ensure that true aim finds the true target”
Investment is a long journey. We aim high, but our true objective is steady, sustainable returns that endure over time.
Team
People are Blueprint Capital’s most important asset. Our team brings together professionals trained at Stanford, UC Berkeley, the University of Pennsylvania, and Carnegie Mellon, with deep experience in mergers and acquisitions, venture capital and private equity, quantitative analysis, and legal advisory. We are further strengthened by long-standing relationships with leading investment groups and seasoned investors.
We share one conviction: helping exceptional businesses realize their full potential is both deeply rewarding and a powerful force for growth.
Expertise
- Mergers & Acquisitions
- Venture Capital & Private Equity
- Quantitative Analysis
- Legal Advisory
Institutions
- Stanford
- UC Berkeley
- University of Pennsylvania
- Carnegie Mellon
Contact us
We operate from four offices across the United States and Greater China. Send us a message and a member of the team will be in touch.
- San Francisco
- New York
- Hong Kong
- Shanghai